Thanks for this - I was waiting for the mad sell out to stop and ask the company on the recent T20
I agree on the Technology - I agree on the nerve/belief on the T20 holders - to keep holding on while the pricing went all the way up and down
What disappointed me was the amount of shares increased by the company by dilution
One can claim it's the strategy to increase the market value of the company to make it more than 100Million or beyond.
Or the Normal way a company operates in ASX
Market Cap
Total Shares xShare Price
June 2022
1,121,218,534 x 0.029 =32.5Million
Market Cap without dilution
322,742,824x0.029 = 9.3Million
Or would there be a chance of increase in share price if there was no dilution happened?
I believe in the Technology - it sounds great - it would help patients find the treatment what they require in shortest time frame - But the way the overall things moving - we need to speedup - Trial - Magsense Device Manufacturing - Device Rollout - Device FDA Clearance - Patient benefitting/Shareholder benefitting - Long way to go - Lets see the rides we take
DYOR!
- Forums
- ASX - By Stock
- IBX
- T20 IBX
T20 IBX, page-36
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
0.001(2.17%) |
Mkt cap ! $2.022M |
Open | High | Low | Value | Volume |
4.7¢ | 4.7¢ | 4.7¢ | $294 | 6.25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 52082 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 10995 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 52082 | 0.048 |
2 | 10798 | 0.047 |
3 | 145755 | 0.046 |
4 | 122509 | 0.045 |
1 | 165000 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 27847 | 1 |
0.060 | 23574 | 2 |
0.063 | 38873 | 1 |
0.070 | 822 | 2 |
0.075 | 61061 | 1 |
Last trade - 10.17am 13/11/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online